Home
Conditions
Carcinoma, Hepatocellular

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 531 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Enrolling by Invitation

FAST (Focused Abbreviated Screening Technique)-MRI Study

NCT04539717

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Enrolling by Invitation

JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study

NCT06882876

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Xiangya Hospital Changsha, Hunan, China

View Trial Details

Enrolling by Invitation

Prehabilitation and Posttransplant Training Program in Liver Transplantation

NCT04246970

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: Hospital Universitari i Politècnic La Fe Valencia, Spain

View Trial Details

Enrolling by Invitation

Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

NCT07088081

Conditions: Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +14 more
Locations: Ain Shams University Cairo, Abbasya, Egypt

View Trial Details

Enrolling by Invitation

The Efficacy of Sequential RT After Triple Therapy for uHCC

NCT07052448

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Fuzhou University Affiliated Provincial Hospital Fuzhou, Fujian, China

View Trial Details

Enrolling by Invitation

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

NCT07046832

Conditions: Adenocarcinoma, Biopsy, Carcinoma, +23 more
Locations: MedStar Georgetown Hospital Washington D.C., District of Columbia, United States

MedStar Washington Hosptial Center Washington D.C., District of Columbia, United States

NewYork-Presbyterian Weill Cornell Medical Center New York, United States

View Trial Details

Enrolling by Invitation

AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer

NCT07042841

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Beijing Tsinghua Chang Gung Hospital Beijing, Beijing Municipality, China

View Trial Details

Enrolling by Invitation

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

NCT06712017

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

The First Affiliated Hospital of Jinan University Jinan, Guangdong, China

Xi'An International Medical Center Hospital Xi’an, Guangxi, China

No.1 Affiliated Hospital of Xian Jiaotong University Xi’an, Shanxi, China

View Trial Details

Enrolling by Invitation

A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery

NCT06647264

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Department of hepatobiliary surgery, Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Enrolling by Invitation

Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT06540508

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular trial results

Related conditions